5Yakovenko S A, Zorina I V, Dmitrieva N V, et al. Intra- venous Administration (IVI) of Calcium (CA) Effectively Pre- vents the Development of Mild and Severe Forms of Ovarian Hyperstimulation Syndrome (OHSS)[ J ]. Fertility and Sterility, 2009,92(3):236.
3Perner A, Andresen L, Pedersen G, et al. Superoxide production and expression of NAD pH oxidases by trans formed and primary human colonic epithelial cells [J]. Gut,2003,52(2):231.
4Teruel MJ,Carbonell LF, Llanos MC,et al. Hemodynamic state the role of angiotensin Ⅱ in ovarian hyperstimula tion syndrome in the ralobit[J]. Fertil Steril, 2002,77 (6) 1256.
5Garcia Velasco JA, Pellicer A. New concepts in the understanding of the ovarian hyperstimulation syndrome [J]. Curr Opin Obstet Gynecol, 2003,15 (3) : 251.
6Artini PG,Fasciani A, Monti M, et al. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program[ J ]. Fertil Steril, 1998,70 ( 3 ) : 560.
7Aboulghar MA, Mansour RT, Serour GI, et al. Elevated levels of interleukin 2, soluble interleukin-2 receptor al pha,interleukin-6, soluble interieukin-6 receptor and vas cular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 1999, 87 (1):81.
8Ludwig M,Jelkmann W,Bauer O,et al. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration[J]. Hum Reprod,1999,14(10) :2437.
9Pau E, Alonso-Muriel I,Gomez R, et al. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarianhyperstimulation syndrome[J]. Hum Reprod, 2006,21 (6) : 1453.
10Kung FT, Chang SY, H uang FJ, et al. VEGF, IVF clinical variables and ovarian hyperstimulation syndrome: a pro spective study of the preimplantation luteal phase [J]. J Reprod Mecl,2007,52(5) :365.
